✦ LIBER ✦

EFFECTS OF AN ORALLY ACTIVE VASOPRESSIN V1 RECEPTOR ANTAGONIST

✍ Scribed by L. M. Burrell; P. A. Phillips; J. Stephenson; J. Risvanis; A-M. Hutchins; C. I. Johnston

Book ID: 108936309
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 315 KB
Volume: 20
Category: Article
ISSN: 0305-1870
DOI: 10.1111/j.1440-1681.1993.tb01713.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolvaptan, an Orally Active Vasopressin

Tolvaptan, an Orally Active Vasopressin V2-Receptor Antagonist-Pharmacology and Clinical Trials

✍ Miyazaki, Toshiki ;Fujiki, Hiroyuki ;Yamamura, Yoshitaka ;Nakamura, Shigeki ;Mor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB

OPC-21268: An Orally Effective, Nonpepti

OPC-21268: An Orally Effective, Nonpeptide Vasopressin V1Antagonist

✍ Kohmoto, Osami ;Serizawa, Takashi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Metiamide—An orally active histamine H2-

Metiamide—An orally active histamine H2-receptor antagonist

✍ J. W. Black; W. A. M. Duncan; J. C. Emmett; C. R. Ganellin; T. Hesselbo; M. E. P 📂 Article 📅 1994 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 505 KB

Metiamide — An orally active histamine H

Metiamide — An orally active histamine H2-receptor antagonist

✍ J. W. Black; W. A. M. Duncan; J. C. Emmett; C. R. Ganellin; T. Hesselbo; M. E. P 📂 Article 📅 1973 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 413 KB

Orbofiban: An orally active GPIIb/IIIa p

Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist

✍ Nancy S. Nicholson; Norman A. Abood; Susan G. Panzer-Knodle; Leo G. Frederick; J 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract A key role has been established for platelet activation and thrombus formation in the pathogenesis of acute coronary syndromes, and restenosis after percutaneous interventions. Antiplatelet agents that have a wider spectrum of activity than aspirin, and clopidogrel would be expected to

ChemInform Abstract: Synthesis and Chara

ChemInform Abstract: Synthesis and Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Antagonists.

✍ Takehiko Ohkawa; Tatsuya Zenkoh; Masayuki Tomita; Naomi Hosogai; Keiji Hemmi; Hi 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views